Comunicati Stampa
Information Technology

Significant Case Intake Efficiencies Found in Newly Launched Life Sciences Generative AI Solution

In the face of soaring volumes of data coming from multiple, diverse sources, Advanced Intake leverages the latest intelligent automation technologies, including Generative AI and Large Language Models (LLMs), to revolutionize adverse event (AE) intake. In the face of soaring volumes of data coming from multiple, diverse sources, Advanced Intake leverages the latest intelligent automation technologies, including Generative AI and Large Language Models (LLMs), to revolutionize adverse event (AE) intake...
BOSTON, (informazione.it - comunicati stampa - information technology)

In the face of soaring volumes of data coming from multiple, diverse sources, Advanced Intake leverages the latest intelligent automation technologies, including Generative AI and Large Language Models (LLMs), to revolutionize adverse event (AE) intake.

As demonstrated in early pilots, Advanced Intake delivers .

Advanced Intake features Dynamic Data Extraction, meaning the system can intelligently process forms regardless of number, variation, or formatting inconsistencies. With Dynamic Data Extraction, no configuration of forms is required. The traditional, manual process of case processing that has been required previously, to account for variability, is revolutionized with Advanced Intake, increasing efficiency in the overall handling of AE case data.

Organizations leveraging Advanced Intake gain added benefits such as:

Commenting on the importance of Advanced Intake to the industry, Ann-Marie Orange , CIO and Global Head of R&D at ArisGlobal, said: "

ArisGlobal, which announced a series of product innovations at its recent conference in London, UK , is the first life sciences R&D technology company to unveil targeted solutions that make impactful use of Generative AI in the industry. Meanwhile, the company continues to host the industry-leading GenAI Council , convening top pharmaceutical executives, academia, and AI thought leaders to further fuel adoption of next-generation technologies across life sciences.

ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, is transforming the way today's most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States , ArisGlobal has regional offices in Europe , India , Japan , and China . For more updates, follow ArisGlobal on LinkedIn or visit www.arisglobal.com .

View original content: https://www.prnewswire.co.uk/news-releases/significant-case-intake-efficiencies-found-in-newly-launched-life-sciences-generative-ai-solution-302124524.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili